Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) — Stella

Home/Dengue Fever/Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

View on ClinicalTrials.gov

Recruiting

Back to Dengue Fever trials

Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Colombia

Cien Salud IPS SAS, Barranquilla, Atlántico

Clinica de la Costa SAS, Barranquilla, Colombia

Key details

Phase

Safety & dosing

Sponsor

George Washington University

Collaborators

Naval Medical Research Center, Clinica de la Costa

Enrollment target

~74 participants

Started

March 2024

Primary completion

September 2026

Age range

7 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.